Artios Announces Oversubscribed $115 Million Series D Financing to Accelerate Clinical Programs in Indications of High Unmet Need GlobeNewswire November 17, 2025 Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios' potential first-in-class ATR Inhibitor, alnodesertib Following encouraging ESMO data presentation, Artios will initiate a randomized Phase 2 […]

Hummink raises $20 million to bring micronic precision printing to advanced manufacturing Hummink is redefining how the world's smallest technologies are made, using ultra-precise printing to fix microscopic flaws and power the next generation of chips and displays. GlobeNewswire November 17, 2025 Paris, Nov. 17, 2025 (GLOBE NEWSWIRE) — As microelectronics underpin the rise of

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases GlobeNewswire November 17, 2025 Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRI Phase 2b clinical trial expected to complete enrollment and have topline data in 1H26 SYDNEY,

Industry-first SDV Maturity Framework brings clarity and urgency to auto industry GlobeNewswire November 17, 2025 Four defined phases of maturity enable automakers, suppliers and partners to benchmark progress and strategically move forward on next-gen experiences Amsterdam – HERE Technologies, the leading mapping and technology company, announced the automotive industry's first data-driven Software-Defined Vehicle (SDV) Maturity

EverCommerce to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference GlobeNewswire November 17, 2025 DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) — EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that Chief Executive Officer Eric Remer and SVP, Finance, & Head of Investor Relations

Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit GlobeNewswire November 17, 2025 BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in a panel discussion at the TD Cowen

SAN FRANCISCO, CA / ACCESS Newswire / November 17, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Baxter International, Inc. ("Baxter") (NYSE:BAX) who purchased or otherwise acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period") to contact us immediately regarding the

Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals and carbon compounds, today announced that the company will host meetings with the investment community as part of its participation in the Southwest IDEAS Investor Conference, which will be held in Dallas, on November 20, 2025. https://mma.prnewswire.com/media/432033/Koppers_Holdings_Inc_Logo.jpg Koppers management

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (NYSE: FUN) common stock pursuant or traceable to the company's registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair,

NEW YORK, NY / ACCESS Newswire / November 17, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177682&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call